26
|
Nicolay JP, Albrecht JD, Assaf C, Dippel E, Stadler R, Wehkamp U, Wobser M, Burghaus I, Schneider S, Guelow K, Goerdt S, Krammer PH. Dimethyl fumarate (DMF) therapy in CTCL: final results from a clinical phase II study. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00593-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
27
|
Schneider S, Leer S. Sport und Klimawandel – Welche Folgen hat der Klimawandel
für den Sport? DAS GESUNDHEITSWESEN 2022. [DOI: 10.1055/s-0042-1753890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
28
|
Andreas M, Szafran D, Vollstädt-Klein S, Grundinger N, Mons U, Lohner V, Görig T, Schneider S. „Dauernuckler“ oder „Genussdampfer“?
Eine netnographische Analyse selbstberichteter Anzeichen möglicher
Abhängigkeitssymptome in E-Zigaretten-Online-Foren. DAS GESUNDHEITSWESEN 2022. [DOI: 10.1055/s-0042-1753571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
29
|
Schneider S, Pollet M, Majora M, Faßbender S, Marini A, Hüsemann J, Knechten M, Schwender H, Krutmann J. 614 Intrinsic versus extrinsic skin aging: Extrinsically differ from intrinsically aged human skin fibroblasts in their metabolic adaptive responses and by carrying a signature of catastrophic failure. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
30
|
Herr R, Mayer A, Wiedemann E, Diehl K, De Bock F, Blume M, Hoffmann S, Herke M, Reuter M, Iashchenko I, Schneider S. Die Rolle der sozio-ökonomischen Position und des
institutionellen Betreuungsumfeldes für die Gesundheit von
Kindergartenkindern. DAS GESUNDHEITSWESEN 2022. [DOI: 10.1055/s-0042-1753868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
31
|
Schneider S, Richter C, Beisel L. Überdosierungen von Heroin – Sozial- und
präventivmedizinische Ansatzpunkte zur Verhinderung dieser
Haupttodesursache nach illegalem Drogenkonsum. DAS GESUNDHEITSWESEN 2022. [DOI: 10.1055/s-0042-1753787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
32
|
Iashchenko I, Schüttig W, Bammert P, Spallek J, Rattay P, Schneider S, Moor I, Pischke CR, Sundmacher L. Die Rolle der regionalen Gesundheitspolitik für die
sozioökonomische Ungleichheit in der Inanspruchnahme der
Gesundheitsleistungen. DAS GESUNDHEITSWESEN 2022. [DOI: 10.1055/s-0042-1753865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
33
|
Dippel N, In-Albon T, Schneider S, Christiansen H, Brakemeier EL. Correction: Investigating the feasibility and effectiveness of a modular treatment program for children and adolescents with depression and interpersonal problems: study protocol of a quasi-experimental pilot feasibility trial (CBASP@YoungAge). Pilot Feasibility Stud 2022; 8:157. [PMID: 35897058 PMCID: PMC9327404 DOI: 10.1186/s40814-022-01118-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
34
|
Dippel N, In-Albon T, Schneider S, Christiansen H, Brakemeier EL. Investigating the feasibility and effectiveness of a modular treatment program for children and adolescents with depression and interpersonal problems: study protocol of a quasi-experimental pilot feasibility trial (CBASP@YoungAge). Pilot Feasibility Stud 2022; 8:145. [PMID: 35821072 PMCID: PMC9275387 DOI: 10.1186/s40814-022-01091-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2022] [Accepted: 06/07/2022] [Indexed: 12/12/2022] Open
Abstract
Background Depression is a serious disorder in childhood and adolescence. Affected children and adolescents show significant impairments in various aspects of life. Studies on the effectiveness or efficacy of psychotherapy in depressed children and adolescents are qualitatively very heterogeneous and reveal small effect sizes. There is thus a need to better tailor psychotherapy approaches to these age groups to improve outcomes like parent-child relationship, symptomatology, or quality of life. To address this gap, we designed a modular, individualized treatment program for children and adolescents based on the Cognitive Behavioral Analysis System of Psychotherapy (CBASP) including caregiver involvement. Method This quasi-experimental pilot feasibility trial is a phase 1 to phase 2 study investigating the feasibility and effectiveness of CBASP@YoungAge by including an intervention group (CBASP@YoungAge) and a treatment-as-usual control group. The treatment of depressive symptoms as well as interpersonal problems with primary caregivers are the main targets of CBASP@YoungAge. Personalization is ensured concerning the treatment course, caregivers’ involvement, and the patient’s age. The primary outcome relates to two areas: the feasibility of the CBASP@YoungAge treatment program in an outpatient context and a change in patients' depressive symptomatology from before to after treatment. We conduct a brief process evaluation after each session in the intervention group to closely monitor the treatment process and examine feasibility from the therapists' and patients' perspectives and mechanisms of symptom change. In addition, we consider interpersonal behavior between children and caregivers, parenting behavior, and monitor the global-health-index in children and parents as secondary outcomes. Pre-, post-, and follow-up data are evaluated. Discussion This is the first study of a modular-based intervention program for children and adolescents with depression and a clear focus on the interpersonal problems between the depressed young patient and her/his caregiver. It will provide important knowledge on the feasibility and effectiveness of the program and potential benefits of including caregivers in psychotherapy. Based on this study’s results, we plan a multicenter, randomized, controlled trial whose long-term aim is to improve the psychotherapeutic care of young patients with depression while preventing persistent courses of depressive disorders. Trial registration German Clinical Trials Register, DRKS (identifier DRKS00023281). Registered 17 November 2020–Retrospectively registered Supplementary Information The online version contains supplementary material available at 10.1186/s40814-022-01091-3.
Collapse
|
35
|
Abeln V, Fomina E, Popova J, Braunsmann L, Koschate J, Möller F, Fedyay SO, Vassilieva GY, Schneider S, Strüder HK, Klein T. Chronic, acute and protocol-dependent effects of exercise on psycho-physiological health during long-term isolation and confinement. BMC Neurosci 2022; 23:41. [PMID: 35773633 PMCID: PMC9244384 DOI: 10.1186/s12868-022-00723-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Accepted: 06/13/2022] [Indexed: 12/27/2022] Open
Abstract
Exercise could prevent physical and psychological deteriorations, especially during pandemic times of lock-down scenarios and social isolation. But to meet both, the common exercise protocols require optimization based on holistic investigations and with respect to underlying processes. This study aimed to explore individual chronic and acute effects of continuous and interval running exercise on physical and cognitive performance, mood, and affect and underlying neurophysiological factors during a terrestrial simulated space mission. Six volunteers (three females) were isolated for 120 days. Accompanying exercise training consisted of a continuous and interval running protocol in a cross-over design. Incremental stage tests on a treadmill were done frequently to test physical performance. Actigraphy was used to monitor physical activity level. Cognitive performance, mood (MoodMeter®), affect (PANAS), brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1), vascular-endothelial growth factor (VEGF), and saliva cortisol were investigated prior to, four times during, and after isolation, pre- and post-exercise on two separate days, respectively. As a chronic effect, physical performance increased (and IGF-1 tended) in the course of isolation and training until the end of isolation. Subjective mood and affect state, as well as cognitive performance, basal BDNF and VEGF levels, were well-preserved across the intervention. No acute effects of exercise were detected, besides slower reaction time after exercise in two out of nine cognitive tests, testing sensorimotor speed and memory of complex figures. Consistently higher basal IGF-1 concentrations and faster reaction time in the psychomotor vigilance test were found for the continuous compared to the interval running protocol. The results suggest that 120 days of isolation and confinement can be undergone without cognitive and mental deteriorations. Regular, individual aerobic running training supporting physical fitness is hypothesized to play an important role in this regard. Continuous running exercise seems to trigger higher IGF-1 levels and vigilance compared to interval running. Systematic and prolonged investigations and larger sample size are required to follow up on exercise-protocol specific differences in order to optimize the exercise intervention for long-term psycho-physiological health and well-being.
Collapse
|
36
|
Landsberg R, Schneider S, Masalha M, Margulis A, Guindy M, Luckman J. Comparison of CT and adjusted MRI for evaluating paranasal sinuses surgical key landmarks. RHINOLOGY ONLINE 2022. [DOI: 10.4193/rhinol/21.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Background: Sinus CT is the imaging technique of choice for planning endoscopic sinus surgery (ESS). Although MRI has a better soft tissue demonstration, it is not commonly used for ESS due to suboptimal bone demonstration. We hypothesised that adjustment of certain MRI parameters, would allow better demonstration of bones and enable the surgeon to adequately identify surgical landmarks. Methodology: Twenty patients identified as candidates for ESS underwent CT and adjusted MRI exams of the paranasal sinuses (40 in total). rhinologist and a neuroradiologist independently compared and graded 46 bony structures (23 on each side) in each patient's CT and MRI. Overall, 920 anatomical structures were graded by each observer (1840 structures in total). Statistical analysis included overall and per variable grading distribution for each observer, and overall agreement. Results: MRI images were equal, or superior to CT for assessing paranasal anatomy in 66.8% and 86.4% of structures evaluated by the rhinologist and neuroradiologist, respectively. Overall agreement between observers (77%) was moderate. Conclusion: The rhinologist prefers CT demonstration of bony structures, while the neuroradiologist prefers MRI. Still, with the MRI protocol used in this study, according to both, most bony structures are well demonstrated by MRI.
Collapse
|
37
|
Debieuvre D, Auliac J, Bylicki O, Moreau L, Corre R, Pinsolle J, Bizieux Thaminy A, Schneider S, Godbert B, Renault P, Brun P, Bernardi M, Briens E, Lepoulain Doubliez M, Delclaux B, Petit L, Bizec J, Milliet de Faverges G, Al Freijat F, Quieffin J. 132P 20 years of real life nationwide epidemiological data on lung cancer in non-academic French public hospitals: KBP-2020-CPHG compared to 2000 and 2010 studies. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
38
|
Dreßen M, Luzius T, Lahm H, Neb I, Doppler SA, Schneider S, Dzilic E, Lange R, Krane M. Establishment of an induced pluripotent stem cell line DHMi005-A from a healthy male proband. Stem Cell Res 2022; 59:102662. [PMID: 35033855 DOI: 10.1016/j.scr.2022.102662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 01/06/2022] [Indexed: 11/18/2022] Open
Abstract
We generated an induced pluripotent stem cell (iPSC) line from a healthy male 29-year-old proband. Adipose fibroblasts (AFs) were reprogrammed using Sendai virus. Generated iPSCs showed typical stem cell morphology. From passage 9 on, iPSCs were free of virus. Pluripotency in the iPSCs was verified and spontaneous differentiation showed expression of all three germ layers. Karyotyping indicated no anomalies for the generated iPSCs. Many patient-specific iPSCs are generated from subcutaneous fat fibroblasts obtained during surgical procedure. The described control iPSC line was generated equally and therefore serves as an ideal control for adipose-fibroblast-based patient-specific iPSC lines in disease modeling.
Collapse
|
39
|
Hebestreit H, Zeidler C, Schippers C, de Zwaan M, Deckert J, Heuschmann P, Krauth C, Bullinger M, Berger A, Berneburg M, Brandstetter L, Deibele A, Dieris-Hirche J, Graessner H, Gündel H, Herpertz S, Heuft G, Lapstich AM, Lücke T, Maisch T, Mundlos C, Petermann-Meyer A, Müller S, Ott S, Pfister L, Quitmann J, Romanos M, Rutsch F, Schaubert K, Schubert K, Schulz JB, Schweiger S, Tüscher O, Ungethüm K, Wagner TOF, Haas K, Akkaya F, Babka C, Bârlescu L, Bärsch-Michelmann A, Bergbreiter A, Blömeke J, Böhm L, Böttger B, Braun B, Brinkmann F, Britz V, Cario H, Celiker M, de Greck M, Debatin KM, Dillmann-Jehn K, Ertl M, Ettinger M, Eymann J, Frommer J, Gabrian M, Glode A, Gödecke V, Grasemann C, Grauer E, Greger H, Haas A, Haase M, Haisch L, Heinrich I, Held M, Hennermann J, Herrmann-Werner A, Hett J, Hilbig B, Holthöfer L, Imhof C, Jacob T, Junne F, Karl S, Kassubek J, Kick L, Koschitzki KT, Krassort H, Kratz C, Kristensen K, Kropff B, Kuhn J, Latzko P, Loew T, Lorenz D, Ludolph AC, dos Santos IM, Meyer T, Mohnike K, Monninger M, Musacchio T, Nanciu AN, Nießen M, Nöhre M, Papagianni A, Pfeifer-Duck C, Piduhn LS, Rampp C, Richter A, Rieß O, Schmidt A, Schneider S, Schoels L, Schwalba M, Selig U, Spangenberger A, Sroka A, Steinbüchel T, Stösser S, Suchant S, Vogel M, Volk D, Vollmuth C, Volnov S, Walter S, Warrings B, Weiler C, Witt S, Zajt KK, Zeltner L, Zenker K, Zhang KD, Zipfel S. Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet J Rare Dis 2022; 17:47. [PMID: 35164804 PMCID: PMC8842899 DOI: 10.1186/s13023-022-02176-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2021] [Accepted: 01/16/2022] [Indexed: 11/12/2022] Open
Abstract
Background In individuals suffering from a rare disease the diagnostic process and the confirmation of a final diagnosis often extends over many years. Factors contributing to delayed diagnosis include health care professionals' limited knowledge of rare diseases and frequent (co-)occurrence of mental disorders that may complicate and delay the diagnostic process. The ZSE-DUO study aims to assess the benefits of a combination of a physician focusing on somatic aspects with a mental health expert working side by side as a tandem in the diagnostic process. Study design This multi-center, prospective controlled study has a two-phase cohort design. Methods Two cohorts of 682 patients each are sequentially recruited from 11 university-based German Centers for Rare Diseases (CRD): the standard care cohort (control, somatic expertise only) and the innovative care cohort (experimental, combined somatic and mental health expertise). Individuals aged 12 years and older presenting with symptoms and signs which are not explained by current diagnoses will be included. Data will be collected prior to the first visit to the CRD’s outpatient clinic (T0), at the first visit (T1) and 12 months thereafter (T2). Outcomes Primary outcome is the percentage of patients with one or more confirmed diagnoses covering the symptomatic spectrum presented. Sample size is calculated to detect a 10 percent increase from 30% in standard care to 40% in the innovative dual expert cohort. Secondary outcomes are (a) time to diagnosis/diagnoses explaining the symptomatology; (b) proportion of patients successfully referred from CRD to standard care; (c) costs of diagnosis including incremental cost effectiveness ratios; (d) predictive value of screening instruments administered at T0 to identify patients with mental disorders; (e) patients’ quality of life and evaluation of care; and f) physicians’ satisfaction with the innovative care approach. Conclusions This is the first multi-center study to investigate the effects of a mental health specialist working in tandem with a somatic expert physician in CRDs. If this innovative approach proves successful, it will be made available on a larger scale nationally and promoted internationally. In the best case, ZSE-DUO can significantly shorten the time to diagnosis for a suspected rare disease. Trial registration ClinicalTrials.gov; Identifier: NCT03563677; First posted: June 20, 2018, https://clinicaltrials.gov/ct2/show/NCT03563677.
Collapse
|
40
|
Danel Buhl N, Vaillant MF, Schneider S, Seguy D, Lescut D. Épidémiologie régionale de la nutrition artificielle à domicile chez l’adulte en France en 2019. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Guimber D, Ley D, Danel Buhl N, Vaillant MF, Schneider S, Lescut D. Démographie exhaustive de la Nutrition Artificielle à Domicile (NAD) chez l’enfant en France en 2019. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Joly F, Quilliot D, Chambrier C, Schneider S, Fotsing G, Poullenot F, Layec S, Flori N, Thibault R, Fontaine E, Ressiot E, Campana V, Schmidely N, Seguy D. EQUATIVE : étude française de la qualité de vie des adultes atteints d’un syndrome de grêle court sous Teduglutide. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
43
|
Danel Buhl N, Vaillant MF, Schneider S, Lescut D. Démographie de la Nutrition Entérale à Domicile (NEAD) chez l’adulte en France en 2019. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
44
|
Abeck F, Booken N, Schneider S. [Inappropriate systemic therapy in severe atopic dermatitis-severe long-term damage]. Hautarzt 2021; 73:638-640. [PMID: 34905073 PMCID: PMC9358965 DOI: 10.1007/s00105-021-04922-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/08/2021] [Indexed: 11/18/2022]
Abstract
Die Therapiemöglichkeiten der schweren atopischen Dermatitis waren bis vor Kurzem sehr begrenzt und haben sich mit der Zulassung des ersten Biologikums Dupilumab Ende 2017 bis heute deutlich verbessert. Aktuell wurden mit dem Biologikum Tralokinumab sowie den Januskinase-Inhibitoren Baricitinib und Upadacitinib weitere neue Systemtherapeutika zugelassen. Dennoch gibt es Fälle, in denen es zur Nichtberücksichtigung moderner Behandlungsmöglichkeiten kommt, wie die Falldarstellung eines 28-jährigen Patienten mit schwerwiegenden Nebenwirkungen einer Langzeitbehandlung mit systemischen Glukokortikosteroiden zeigt. Neben der umfangreichen Abklärung der Folgeschäden, erfolgten die Einleitung einer leitliniengerechten Therapie mit Dupilumab sowie eine interdisziplinäre Zusammenarbeit mit Endokrinologen, Ophthalmologen, Osteologen und Ernährungsmedizinern.
Collapse
|
45
|
Dreßen M, Lahm H, Neb I, Luzius T, Doppler SA, Schneider S, Dzilic E, Lange R, Krane M. Establishment of a patient-specific induced pluripotent stem cell line DHMi004-A from a male Holt-Oram syndrome patient with verified TBX5 mutation. Stem Cell Res 2021; 58:102617. [PMID: 34894535 DOI: 10.1016/j.scr.2021.102617] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Revised: 12/01/2021] [Accepted: 12/05/2021] [Indexed: 11/27/2022] Open
Abstract
The Holt-Oram syndrome (HOS) is a rare autosomal dominant disorder, mostly based on mutations in the TBX5 gene. Patients show malformation of at least one upper limb along with congenital heart defects. The established induced pluripotent stem cell (iPSC) line was generated from a patient displaying pronounced and typical features of HOS and carrying a single-nucleotide change c.920_C>A leading to an amino acid change from proline to threonine at amino acid position 85, which appeared de novo. Adipose fibroblasts from the patient were reprogrammed using Sendai virus. Pluripotency of the iPSCs was fully demonstrated.
Collapse
|
46
|
Tarantino S, Sulz I, Barazzoni R, Cuerda-Compes C, Schneider S, Hiesmayr M. Covid-19 hospitalized patients at nutritionday: use of enteral nutrition, parenteral nutrition or oral nutritional supplements is associated with being bedridden, not being allowed to eat, low appetite and low bmi. Clin Nutr ESPEN 2021. [PMCID: PMC8629523 DOI: 10.1016/j.clnesp.2021.09.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
47
|
Lamy T, Cabarrou B, Planchard D, Quantin X, Schneider S, Bringuier M, Robain M, Besse B, Simon G, Baldini C. Molecular testing in older patients treated for an advanced or metastatic nonsquamous non-small-cell lung cancer. J Geriatr Oncol 2021. [DOI: 10.1016/s1879-4068(21)00328-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
48
|
Fischer A, Barazzoni R, Tarantino S, Laviano A, Veraar C, Sulz I, Schneider S, Lassnigg A, Cuerda-Compes C, Pestana E, Hiesmayr M. Does bmi affect the use of enteral and parenteral nutrition in the ward: a nutritionday analysis in 191 886 adult patients. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
49
|
Joly F, Quilliot D, Chambrier C, Schneider S, Fotsing G, Poullenot F, Layec S, Flori N, Thibault R, Fontaine E, Ressiot E, Campana V, Schmidely N, Seguy D. Equative: quality of life in adult patients with short bowel syndrome treated by teduglutide, a french real-world study. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
50
|
Kurukulaarachchi S, Caroli-Bosc P, Gillis V, Szczepanek K, Wanten G, Schneider S, Forbes A. Thrombotic and haemorrhagic complications of home parenteral nutrition. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|